|
JP2006305345A
|
|
Drug for relieving carbonyl stress state and peritoneal dialysate
|
|
AU2004294435A1
|
|
Inhibitor of protein modification products formation
|
|
JP2004325444A
|
|
Protein modifier production inhibitor and evaluation method thereof
|
|
JP2004300153A
|
|
Protein modification product formation inhibitor
|
|
WO03084998A1
|
|
Monoclonal antibody neutralizing megsin
|
|
WO03066089A1
|
|
Megsin ligands
|
|
JP2003342296A
|
|
Megsin activity inhibitor
|
|
JP2003310268A
|
|
Transcriptional regulatory sequence and use thereof
|
|
WO0247677A1
|
|
Agents for ameliorating carbonyl stress
|
|
JP2002291879A
|
|
Domiciliary treatment management system
|
|
AU2226001A
|
|
Method of diagnosing mesangium proliferative nephritis in rat
|
|
CA2385984A1
|
|
Animal model for mesangial proliferative nephritis
|
|
WO0124790A1
|
|
Agents for relieving carbonyl stress
|
|
WO0066729A1
|
|
Meg-3 protein
|
|
CA2366651A1
|
|
A method for detecting megsin protein and use thereof
|
|
CA2358928A1
|
|
Megsin promoter
|
|
WO0010606A1
|
|
Drugs for relieving carbonyl stress and peritoneal dialysates
|
|
WO9915652A1
|
|
Megsin protein
|
|
JPH11155608A
|
|
Antislipping belt and sole for snow-covered road
|
|
JPH11116941A
|
|
Nonskid mixed agent for ice and snow
|
